Comparable stake leader
Ethan Shen PhD
SEC ownership of YD Bio Ltd
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002011674.
Disclosed value leader
Ethan Shen PhD
Comparable rows
13/21
Latest evidence
30 Jun 2026
- Public ticker
- YDES, YDESW on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Ethan Shen PhD
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
13 of 21
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Ethan Shen PhD
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0002011674
- Issuer location
- Irving, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of YD Bio Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ethan Shen PhD
Disclosed value leader
Ethan Shen PhD
Comparable rows
13/21
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 77%
8 rows are not safely comparable across share classes.
13D/G row: Ethan Shen PhD
Showing 1-8 of 21 holder rows.
Quick read
Ethan Shen PhD leads the comparable SEC ownership view at 77%.
13 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ethan Shen PhD's linked filing trail.
Comparable ownership
Top 5
Ethan Shen PhD
77%
Shao-Ta Lu
0.08%
Bo-Xiang Zhang
0.04%
Kochi Chang
0.01%
Garrett Wealth Advisory Group, LLC
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 21 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ethan Shen PhD |
13D/G
3/4/5
Ethan Shen · CEO, Director
|
77%
|
$663,552,584
54,345,011 shares
|
$0 | 17 Feb 2026 |
| Shao-Ta Lu |
3/4/5
Director
|
0.08%
|
$454,153
58,981 shares
|
— | 30 Jun 2026 |
| Bo-Xiang Zhang |
3/4/5
Chief Medical Officer, Director
|
0.04%
|
$379,608
31,141 shares
|
— | 18 Mar 2026 |
| Kochi Chang |
3/4/5
Director
|
0.01%
|
$60,291
7,830 shares
|
— | 30 Jun 2026 |
| Garrett Wealth Advisory Group, LLC |
13F
Company
|
0.12%
|
$190,418
84,630 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.09%
|
$141,106
62,714 shares
|
— | 30 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.04%
|
$67,739
30,106 shares
|
— | 30 Jun 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.03%
|
$48,202
21,423 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-6 of 6 reporting-owner rows connected to YD Bio Ltd. Open a relationship link for the CIK-to-CIK filing trail.
Rows
6
Largest Forms 3/4/5 holder
Ethan Shen PhD
Net 12M change
$0
Latest report
30 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ethan Shen PhD | CEO, Director | $441,824,938 | Mixed | 18 Mar 2026 | ||
| Shao-Ta Lu | Director | $454,153 | Mixed | 30 Jun 2026 | ||
| Bo-Xiang Zhang | Chief Medical Officer, Director | $379,608 | Mixed | 18 Mar 2026 | ||
| Kochi Chang | Director | $60,291 | Mixed | 30 Jun 2026 | ||
| Man Edmund Hen | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Jerry Yin-Chia Lee | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for YD Bio Ltd
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Shao-Ta Lu | YDES | Ordinary Shares | Options Exercise | 276.3% | 5,749 | 7,830 | 30 Jun 2026 | Direct | ||
| Shao-Ta Lu | YDES | Restricted Share Units | Options Exercise | -100% | -5,749 | 0 | 30 Jun 2026 | Direct | ||
| Shao-Ta Lu | YDES | Restricted Share Units | Award | 5,749 | 5,749 | 30 Jun 2026 | Direct | |||
| Kochi Chang | YDES | Ordinary Shares | Options Exercise | 276.3% | 5,749 | 7,830 | 30 Jun 2026 | Direct | ||
| Kochi Chang | YDES | Restricted Share Units | Options Exercise | -100% | -5,749 | 0 | 30 Jun 2026 | Direct | ||
| Kochi Chang | YDES | Restricted Share Units | Award | 5,749 | 5,749 | 30 Jun 2026 | Direct | |||
| Shao-Ta Lu | YDES | Ordinary Shares | Options Exercise | 2,081 | 2,081 | 31 Mar 2026 | Direct | |||
| Shao-Ta Lu | YDES | Restricted Share Units | Options Exercise | 2,081 | 0 | 31 Mar 2026 | Direct | |||
| Shao-Ta Lu | YDES | Restricted Share Units | Award | 2,081 | 2,081 | 31 Mar 2026 | Direct | |||
| Kochi Chang | YDES | Ordinary Shares | Options Exercise | 2,081 | 2,081 | 31 Mar 2026 | Direct | |||
| Kochi Chang | YDES | Restricted Share Units | Options Exercise | 2,081 | 0 | 31 Mar 2026 | Direct | |||
| Kochi Chang | YDES | Restricted Share Units | Award | 2,081 | 2,081 | 31 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.